{"filing":{"accession_number":"0001099219-26-000048","cik":"0001099219","ticker":"MET-PF","company_name":"METLIFE INC","form":"8-K","filing_date":"2026-08-05","report_date":"2026-08-05","primary_document":"met-20260805.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1099219/000109921926000048/met-20260805.htm"},"events":[{"id":24372,"run_id":22075,"accession_number":"0001099219-26-000048","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"summary":"MetLife issued a news release on August 5, 2026 announcing its second quarter 2026 financial results, including net income of $705 million ($1.09 per share), adjusted earnings of $1.6 billion ($2.43 per share), 7% revenue growth, 18% net investment income growth, and 17% adjusted ROE.","company_name":"METLIFE INC","ticker":"MET-PF","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":24892,"accession_number":"0001099219-26-000048","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"MetLife issued a news release on August 5, 2025 announcing its results for the quarter ended June 30, 2026, attached as Exhibit 99.1. The earnings release discloses quarterly financial results including net income of $705 million ($1.09 per share), adjusted earnings of $1.6 billion ($2.43 per share), and segment-level performance metrics. This is a standard quarterly earnings disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:26:24.046109+00:00","company_name":"","ticker":null,"filing_date":""},{"id":24893,"accession_number":"0001099219-26-000048","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"MetLife disclosed its second quarter 2026 financial results via an earnings release (EX-99.1) showing net income of $705 million ($1.09 per share) and adjusted earnings of $1.6 billion ($2.43 per share), with key metrics including 7% revenue growth, 18% net investment income growth, and 17% adjusted ROE. The Item 7.01 disclosure explicitly references the \"Earnings Release and Quarterly Financial Supplement\" and the earnings call presentation, which is the standard format for quarterly earnings disclosures under Regulation FD.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:26:24.046109+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":24373,"run_id":22075,"accession_number":"0001099219-26-000048","anchor_item_number":"8.01","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"MetLife's Board approved a new $3.0 billion authorization to repurchase common stock on August 5, 2026, as part of the company's shareholder return program which returned over $1.1 billion to shareholders via share repurchases and common stock dividends in Q2 2026.","company_name":"METLIFE INC","ticker":"MET-PF","filing_date":"2026-08-05","form":"8-K","submitted_at":null,"items":[{"id":24894,"accession_number":"0001099219-26-000048","item_number":"8.01","item_title":"Other Events.","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Item 8.01 discloses that MetLife's Board approved a new $3.0 billion authorization to repurchase common stock on August 5, 2026. While share repurchase programs are capital allocation decisions, they are typically classified as dividend_distribution events under the taxonomy when disclosed as a formal board authorization. The supplemental earnings release (EX-99.1) notes that MetLife \"returned over $1.1 billion to shareholders via share repurchases and common stock dividends\" in Q2 2026, confirming the repurchase program is an active shareholder return mechanism. The $3.0 billion authorization is material to investors assessing capital allocation and shareholder value creation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:26:24.046109+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":24892,"accession_number":"0001099219-26-000048","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.99,"reasoning":"MetLife issued a news release on August 5, 2025 announcing its results for the quarter ended June 30, 2026, attached as Exhibit 99.1. The earnings release discloses quarterly financial results including net income of $705 million ($1.09 per share), adjusted earnings of $1.6 billion ($2.43 per share), and segment-level performance metrics. This is a standard quarterly earnings disclosure under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:26:24.046109+00:00","company_name":"METLIFE INC","ticker":"MET-PF","filing_date":"2026-08-05"},{"id":24893,"accession_number":"0001099219-26-000048","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"MetLife disclosed its second quarter 2026 financial results via an earnings release (EX-99.1) showing net income of $705 million ($1.09 per share) and adjusted earnings of $1.6 billion ($2.43 per share), with key metrics including 7% revenue growth, 18% net investment income growth, and 17% adjusted ROE. The Item 7.01 disclosure explicitly references the \"Earnings Release and Quarterly Financial Supplement\" and the earnings call presentation, which is the standard format for quarterly earnings disclosures under Regulation FD.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:26:24.046109+00:00","company_name":"METLIFE INC","ticker":"MET-PF","filing_date":"2026-08-05"},{"id":24894,"accession_number":"0001099219-26-000048","item_number":"8.01","item_title":"Other Events.","event_type":"dividend_distribution","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"Item 8.01 discloses that MetLife's Board approved a new $3.0 billion authorization to repurchase common stock on August 5, 2026. While share repurchase programs are capital allocation decisions, they are typically classified as dividend_distribution events under the taxonomy when disclosed as a formal board authorization. The supplemental earnings release (EX-99.1) notes that MetLife \"returned over $1.1 billion to shareholders via share repurchases and common stock dividends\" in Q2 2026, confirming the repurchase program is an active shareholder return mechanism. The $3.0 billion authorization is material to investors assessing capital allocation and shareholder value creation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-06T02:26:24.046109+00:00","company_name":"METLIFE INC","ticker":"MET-PF","filing_date":"2026-08-05"}]}